Navigation Links
National Pharmaceutical Policy Referred to Ministerial Panel

The draft National Pharmaceutical Policy has been referred to a Group of Ministers (GOM) though no timeframe has been set for// its finalisation, Lok Sabha was informed Monday.

The policy envisages ways to make available cheaper drugs to people and the public health system as also to promote the production and marketing of generic drugs in the country, said B.K. Handique, minister of state for chemicals and fertilisers and parliamentary affairs.

The policy was taken up by the cabinet at its meeting on Jan 11 and referred to the GOM which had its first meeting on April 10.

However, 74 bulk drugs and their formulations, in accordance with the drug price control order, are under price control and their prices are fixed or revised by the National Pharmaceutical Pricing Authority (NPPA), the minister said.

The prices of non-Scheduled formulations are fixed by the manufacturers themselves, keeping in view various factors like cost of production, marketing and selling expenses, and market competition, he added.

Source-IANS/V
'"/>




Page: 1

Related medicine news :

1. National Lung Study in the process
2. Indian Nationals with Foreign Medical Degrees can now practice in India
3. Hepatitis B Vaccine To Be Included In National Immunization Programme
4. UK Govt Says On Course For National Chlamydia Screening
5. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
6. India extends National TB Control Program
7. President and Founder of National Obesity Forum Resigns
8. Hwang Woo Suk Suspended By Seoul National University
9. Indian National in Saudi Jail will be released soon
10. National Women and Girls HIV/AIDS Awareness Day
11. Calcutta National Medical College Strike Continues Unabated
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... , ... May 06, 2016 , ... ... arrival of Sovaldi, which made headlines mostly for its cost despite its potential ... and moral questions surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have ...
(Date:5/6/2016)... ... 2016 , ... RowdMap, Inc. co-founder, Joshua Rosenthal, PhD, joins ... Deputy Administrator at Centers for Medicare and Medicaid Services (CMS); Ali Khan, MD, ... Officer at Health Care Service Corporation (Blue Cross and Blue Shield of Illinois, ...
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... the Responsible Wool Standard (RWS) for public stakeholder review. The stakeholder review is an ... that it meets its goals and delivers value to the wool industry., The RWS ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May 6 - ... on steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted in ... will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with ...
(Date:5/5/2016)... Indianapolis, IN (PRWEB) , ... May 05, 2016 ... ... employee benefits advisory organization, announces McLaughlin & Smoak Benefits as the latest addition ... & Smoak Benefits has a dedicated team of compliance, wellness, human resources, and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology: